Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis’ Pluvicto. Read More

How AI can help researchers make esophageal cancer less deadly

That can damage the cells lining the esophagus, prompting them to grow back with genetic mistakes. About 22,370 times a year in the United States, those mistakes culminate in cancer ... technology in ... Read More

Living and Working With Cancer Is the New Reality for Many Americans

The burden of cancer can blow up even the best-laid plans. More than two million people in the U.S. are expected to be diagnosed with the disease this year, and there are more than 18 million ... Read More

After 10 years of game-changing immunotherapies, a cancer conference celebrates — and sees more work to do

BARCELONA, Spain — Ten years ago, a new type of cancer treatment reached the ... and because researchers now have 10 years of data to demonstrate how the drugs are helping patients over the long term. Read More

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ... Read More